NEWS BITES ASIAN MARKETS
Ryman Healthcare Limited (NZSX:RYM), New Zealand's largest finance & other services company by market capitalisation, increased 2.0c (or 0.4%) to close at NZD4.77. The volume was 0.3 times the average trading of 489,816 shares.
Bullish Signals
- The price increased 1.7% in the last week and lifted 2.6% in the last month.
- In the last three months the stock has hit a new 52-week high seven times, pointing to a significant uptrend.
- The present value of NZD1,000 (PV1000) invested one year ago is NZD1,674, including a capital gain of NZD634 and dividend reinvested of NZD40.
PV1000 | 1-week | 1-month | 1-year |
RYM.NZSX | 1,017 | 1,026 | 1,674 |
NZX 50 Index | 992 | 1,024 | 1,251 |
Fundamental measures by comparison with the sector average [in brackets] indicate Undervaluation:
- Price to Book of 3.7 [4.5]. We estimate the shares are trading at a current year Price to Book of 3.1 and a forward year Price to Book of 2.6.
- Return on Equity 18.7% [2.0%].
Other Bullish Signals:
- Interest cover defined by EBIT/I is 19.4 times. This indicates it is less leveraged.
- Tobin's Q Ratio, defined as MCap divided by Total Assets, is 1.2. Compared with the rest of the market the stock is undervalued.
Description | Value | Rank In Market |
Net Profit Margin % | 47 | In Top Quartile |
EBITDA Margin % | 56.1 | In Top Quartile |
MCap | US$2 billion | In Top Quartile |
Price/MAP200 | 1.18 | In Top Quartile |
Interest Cover | 19.4 | In Top Quartile |
Note
Volume: there were 131,046 shares worth NZD625,089 (US$515,135.8) traded.
Beta: the Beta of this stock is 0.3. A Beta lower than 1 suggests this is a low risk, low return stock with volatility less than that of the market.
Fundamental measures by comparison with the sector average [in brackets] indicate Overvaluation:
- Price/Sales of 9.3 [4.7].
- Dividend yield of 1.9% [2.3%].
Bearish Signals:
- Total Liabilities/ EBITDA of 8.8 is more than or equal to 5, this compares unfavourably with the Joseph Piotroski benchmark of 5.
COMPANY ANNOUNCEMENTS
The last 7 company announcements are:
February 07: Ryman Healthcare: Disclosure of Directors and Officers Relevant Interests
